Skip to main content
OpenTrials

Clinical trial condition

Rickets

Explore clinical trials studying Rickets. Study availability and eligibility vary by location and protocol.

101 public trials 16 recruiting studies
Refine in advanced search Browse all conditions

Rickets trial results

Completed

Baby Detect : Genomic Newborn Screening

NCT05687474

Conditions
3-Hydroxy 3-Methyl Glutaric Aciduria, 3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency, 3-Hydroxy-3-Methylglutaryl-CoA Synthase 2 Deficiency, +368 more
Locations
  • CRMN, Hôpital La Citadelle Liège, Wallonia, Belgium
View Trial Details
Completed

Study to Assess the Safety, Tolerability, Pharmacokinetics and Efficacy of Burosumab in Patients Less Than 1 Year of Age

NCT04188964

Conditions
Avitaminosis, Bone Diseases, Bone Diseases, Metabolic, +26 more
Locations
  • Kepler Universitaetsklinikum GmbH Linz, Austria
  • Centre de reference des maladies renales rares-Hospices Civils de Lyon-Hopital Femme Mere Enfant Lyon, France
  • Hopital Kremlin APHP Paris, France
  • Ospedale Pediatrico Bambino Gesù Rome, Italy
View Trial Details
Completed

Efficacy and Safety of Burosumab Versus Oral Phosphate and Active Vitamin D Treatment in Pediatric Patients With XLH

NCT02915705

Conditions
Avitaminosis, Bone Diseases, Bone Diseases, Metabolic, +26 more
Locations
  • Children's Hospital Los Angeles Los Angeles, California, United States
  • UCSF San Francisco, California, United States
  • Indiana University School of Medicine Indianapolis, Indiana, United States
  • Shriners Hospital For Children St Louis, Missouri, United States
View all 16 locations
View Trial Details
Completed

A UK Multicentre, Health-Related Quality of Life Study for Children and Adolescents With XLH

NCT04819490

Conditions
Avitaminosis, Bone Diseases, Bone Diseases, Metabolic, +26 more
Locations
  • Royal Hospital for Sick Children Edinburgh, United Kingdom
  • NHS Greater Glasgow & Clyde- South Glasgow University Hosp Division Glasgow, United Kingdom
  • Leeds Teaching Hospitals NHS Trust, Trust Headquarters, St. James's University Hospital Leeds, United Kingdom
  • Evelina Childrens Hospital London, United Kingdom
View Trial Details
Completed

Study to Assess the Safety, Pharmacokinetics and Efficacy of KRN23 in Adult Chinese Patients With XLH

NCT04842019

Conditions
Avitaminosis, Bone Diseases, Bone Diseases, Metabolic, +26 more
Locations
  • Peking Union Medical College Hospital Beijing, China
  • The First Medical Center of Chinese People's Liberation Army General Hospital Beijing, China
  • Nanfang Hospital Guangzhou, China
  • The Second Affiliated Hospital of Zhejiang University Hangzhou, China
View Trial Details
Completed

Study to Assess the Safety, Pharmacokinetics and Efficacy of KRN23 in Pediatric Chinese Patients With XLH

NCT04842032

Conditions
Avitaminosis, Bone Diseases, Bone Diseases, Metabolic, +26 more
Locations
  • Peking Union Medical College Hospital Beijing, China
  • Guangzhou Women and Children Medical Center Guangzhou, China
  • Shanghai 6th Hospital Shanghai, China
  • Shanghai Xinhua Hopsital Shanghai, China
View Trial Details
Completed

An Extension Study of KRN23 in Adults With X-Linked Hypophosphatemia

NCT01571596

Conditions
Avitaminosis, Bone Diseases, Bone Diseases, Metabolic, +26 more
Locations
  • University of California San Francisco San Francisco, California, United States
  • Yale University School of Medicine New Haven, Connecticut, United States
  • Clinical Research Center, Indiana University School of Medicine Indianapolis, Indiana, United States
  • Duke Clinical Research Unit Durham, North Carolina, United States
View Trial Details
Completed

Study of KRN23 in Adults With X-linked Hypophosphatemia (XLH)

NCT02526160

Conditions
Avitaminosis, Bone Diseases, Bone Diseases, Metabolic, +26 more
Locations
  • Children's Hospital of Los Angeles Los Angeles, California, United States
  • University of California-San Francisco Medical Center San Francisco, California, United States
  • Yale University School of Medicine New Haven, Connecticut, United States
  • Indiana University Department of Medicine Indianapolis, Indiana, United States
View all 25 locations
View Trial Details

Related conditions